Capital Fund Management (CFM)
AGN

Capital Fund Management (CFM)’s Allergan Inc AGN Stock Holding History

Capital Fund Management (CFM)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,900
Closed -$404K – 1970
2014
Q4 		$404K Hold
1,900
– – ﹤0.01% 1221
2014
Q3 		$339K Sell
1,900
-29,500
-94% -$4.9M ﹤0.01% 1283
2014
Q2 		$5.31M Buy
31,400
+8,100
+35% +$1.26M 0.06% 413
2014
Q1 		$2.89M Sell
23,300
-300
-1% -$36.5K 0.04% 537
2013
Q4 		$2.62M Sell
23,600
-28,300
-55% -$2.7M 0.03% 592
2013
Q3 		$4.69M Buy
+51,900
New +$4.66M 0.06% 377

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Capital Fund Management (CFM)'s AGN Position: Q3 2013 in Review

Capital Fund Management (CFM) sold out of Allergan Inc (AGN) in Q3 2013, closing a stake of 111,774 shares — an estimated $10M sold.

Capital Fund Management (CFM) first reported a position in AGN in Q2 2013 and held it in 1 quarter. The position peaked at $9.42M in Q2 2013. 642 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

  • Capital Fund Management (CFM) reported no remaining Allergan Inc position as of Q3 2013 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 111,774 Allergan Inc shares in Q3 2013, an estimated $10M.
  • Capital Fund Management (CFM) first reported a position in Allergan Inc in Q2 2013 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Allergan Inc position peaked at $9.42M in Q2 2013.
  • 642 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2013.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2013, filed 31 Oct 2013.